CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt

被引:2
|
作者
Cannon, Dale S. [1 ]
Mermelstein, Robin J. [2 ,3 ]
Medina, Tait R. [4 ]
Pugach, Oksana [4 ]
Hedeker, Donald [5 ]
Weiss, Robert B. [6 ]
机构
[1] Univ Utah, Sch Med, Dept Psychiat, 650 Komas Dr,Suite 206, Salt Lake City, UT 84108 USA
[2] Univ Illinois, Inst Hlth Res, Chicago, IL USA
[3] Univ Illinois, Policy & Psychol Dept, Chicago, IL USA
[4] Univ Illinois, Inst Publ Hlth Res & Policy, Chicago, IL USA
[5] Univ Chicago, Dept Hlth Sci, Chicago, IL 60637 USA
[6] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84108 USA
基金
美国国家卫生研究院;
关键词
NICOTINE DEPENDENCE; TOBACCO DEPENDENCE; SMOKERS; ASSOCIATION; ADDICTION; BEHAVIOR; GENES; RISK; ADOLESCENTS; METABOLISM;
D O I
10.1093/ntr/ntv244
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: In very novice smokers, CYP2A6 genotypes that reduce nicotine metabolism to an intermediate rate may increase smoking risk, relative to both normal and slow rates. The present study examined the hypothesis that intermediate metabolism variants are associated with greater pleasurable effects of the initial smoking attempt than either normal or slow metabolism variants. Methods: Participants were novice smokers (N = 261, 65% female) of European descent. Predicted nicotine metabolic rate based on CYP2A6 diplotypes (CYP2A6 Diplotype Predicted Rate [CDPR]) was partitioned into Normal, Intermediate, and Slow categories using a metabolism metric. Subjective reactions to the initial smoking attempt were assessed by the Pleasurable Smoking Experiences (PSE) scale, which was collected within 3 years of the initial smoking attempt. The effect of CDPR on PSE was tested using a generalized linear model in which CDPR was dummy coded and Intermediate CDPR was the reference condition. Gender was included in the model as a control for higher PSE scores by males. Results: Lower PSE scores were associated with Normal CDPR, beta = -0.34, P =.008, and Slow CDPR, beta = -0.52, P =.001, relative to Intermediate CDPR. Conclusions: Intermediate CDPR-enhanced pleasurable effects of the initial smoking attempt relative to other CYP2A6 variants. This finding is consistent with the hypothesis that the risk effect of Intermediate CDPR on early smoking is a function of optimal pleasurable effects. Implications: This study supports our recent hypothesis that CYP2A6 diplotypes that encode intermediate nicotine metabolism rate are associated with enhanced pleasurable events following the initial smoking attempt, compared with diplotypes that encode either normal or slow metabolism. This hypothesis was offered to account for our unexpected previous finding of enhanced smoking risk in very novice smokers associated with intermediate metabolism rate. Our new finding encourages further investigation of time-dependent relations between CYP2A6 effects and smoking motives, and it encourages laboratory study of the mechanisms underlying the initial smoking enhancement in novice smokers associated with intermediate metabolism.
引用
收藏
页码:637 / 641
页数:5
相关论文
共 50 条
  • [41] A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent
    Ho, Man Ki
    Mwenifumbo, Jill C.
    Zhao, Bin
    Gillam, Elizabeth M. J.
    Tyndale, Rachel F.
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (01): : 67 - 75
  • [42] Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages
    Perez-Rubio, Gloria
    Alberto Lopez-Flores, Luis
    Ramirez-Venegas, Alejandro
    Noe-Diaz, Valeri
    Garcia-Gomez, Leonor
    Ambrocio-Ortiz, Enrique
    Sanchez-Romero, Candelaria
    De Jesus Hernandez-Zenteno, Rafael
    Humberto Sansores, Raul
    Falfan-Valencia, Ramces
    GENE, 2017, 628 : 205 - 210
  • [43] Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults
    Ando, M
    Hamajima, N
    Ariyoshi, N
    Kamataki, T
    Matsuo, K
    Ohno, Y
    JOURNAL OF EPIDEMIOLOGY, 2003, 13 (03) : 176 - 181
  • [44] Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema
    Minematsu, N
    Nakamura, H
    Iwata, M
    Tateno, H
    Nakajima, T
    Takahashi, S
    Fujishima, S
    Yamaguchi, K
    THORAX, 2003, 58 (07) : 623 - 628
  • [45] Is the association between CYP2A6 and lung cancer mediated through smoking behavior?
    Jee, Yon Ho
    Lee, Suhyun
    Jee, Sun Ha
    Kraft, Peter
    GENETIC EPIDEMIOLOGY, 2020, 44 (05) : 490 - 490
  • [46] CYP2A6 gene defects and duplications alter objective indices of smoking.
    Tyndale, RF
    Rao, Y
    Bodin, L
    Zia, M
    Zeman, M
    Hoffmann, E
    Sellers, EM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 113 - 113
  • [47] CYP2A6 gene variants may explain smoking status in a Turkish cohort
    Pehlivan, Sacide
    Uysal, Mehmet Atilla
    Cagatay, Tulin
    Nursal, Ayse Feyda
    Cinar, Cigdem Kekik
    Erkan, Feyza
    Sever, Ulgen
    Bingol, Zuleyha
    Pehlivan, Mustafa
    Pence, Sadrettin
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 29 (03) : 340 - 345
  • [48] CYP2A6 Genotype and Smoking Behavior in Current Smokers Screened for Lung Cancer
    Styn, Mindi A.
    Nukui, Tomoko
    Romkes, Marjorie
    Perkins, Kenneth A.
    Land, Stephanie R.
    Weissfeld, Joel L.
    SUBSTANCE USE & MISUSE, 2013, 48 (07) : 490 - 494
  • [49] High prevalence of CYP2A6*4 and CYP2A6*9 alleles detected among a Malaysian population
    Yusof, Wardah
    Gan, Siew Hua
    CLINICA CHIMICA ACTA, 2009, 403 (1-2) : 105 - 109
  • [50] Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior
    Thorgeirsson, Thorgeir E.
    Gudbjartsson, Daniel F.
    Surakka, Ida
    Vink, Jacqueline M.
    Amin, Najaf
    Geller, Frank
    Sulem, Patrick
    Rafnar, Thorunn
    Esko, Tonu
    Walter, Stefan
    Gieger, Christian
    Rawal, Rajesh
    Mangino, Massimo
    Prokopenko, Inga
    Magi, Reedik
    Keskitalo, Kaisu
    Gudjonsdottir, Iris H.
    Gretarsdottir, Solveig
    Stefansson, Hreinn
    Thompson, John R.
    Aulchenko, Yurii S.
    Nelis, Mari
    Aben, Katja K.
    den Heijer, Martin
    Dirksen, Asger
    Ashraf, Haseem
    Soranzo, Nicole
    Valdes, Ana M.
    Steves, Claire
    Uitterlinden, Andre G.
    Hofman, Albert
    Tonjes, Anke
    Kovacs, Peter
    Hottenga, Jouke Jan
    Willemsen, Gonneke
    Vogelzangs, Nicole
    Doering, Angela
    Dahmen, Norbert
    Nitz, Barbara
    Pergadia, Michele L.
    Saez, Berta
    De Diego, Veronica
    Lezcano, Victoria
    Garcia-Prats, Maria D.
    Ripatti, Samuli
    Perola, Markus
    Kettunen, Johannes
    Hartikainen, Anna-Liisa
    Pouta, Anneli
    Laitinen, Jaana
    NATURE GENETICS, 2010, 42 (05) : 448 - U135